摘要
Abstract
Objective To investigate the clinical efficacy of montelukast sodium combined with sulphate aerosol albuterol (Ventolin) inhalation in the treatment of children with cough variant asthma.Methods by a random number table method in our hospital 60 cases of children with cough variant asthma were divided into two groups. The control group was given conventional Ventolin inhalation treatment, and the experimental group was treated montelukast sodium combined with Ventolin inhalation therapy, and clinical effects were observed and compared in two groups of children after treatment.Results After treatment the total efficiency rate of the experimental group (96.67%) was significantly higher than the control group (70.00%). In the experimental group the elapsed time of wheezing and lungs wheeze improved (2.85 ± 0.81, 5.26 ± 0.80) d was significantly shorter than the control group (5.31±1.42, 10.35±2.23) d(t=2.649,2.448,P=0.018,0.029); the children in the experimental group peak expiratory flow rate (1.57±0.52) L / min was significantly better than the control group (1.25±0.38) L / min(t=2.317,P=0.033), and there was significant difference(P<0.05).Conclusion Montelukast combined with Ventolin inhalation treatment of cough variant asthma in children has a positive role in enhancing the overall clinical efficiency, improve lung function, safe and effective, should be widely used in clinical practice.关键词
孟鲁司特钠/硫酸沙丁胺醇气雾剂/雾化吸入/小儿咳嗽变异性哮喘Key words
Montelukast sodium/Albuterol sulfate/Aerosol inhalation/Cough variant asthma分类
医药卫生
